Similarly, the levels of mRNA related to liver fibrosis (Col1A1, Acta2, Timp1, and Tgfb1) were significantly increased in the DM group, which were significantly reduced by the LFD treatment. The gene discussed is TGFB1; the disease is diabetes mellitus.